Ch. Rosak
Impact in
-
- Diabetes Management and Research
- Diabetes Treatment and Management
- Diabetes, Cardiovascular Risks, and Lipoproteins
-
- Blood Pressure and Hypertension Studies
- Cardiovascular Function and Risk Factors
Papers in
-
- Diabetes Management and Research 14
- Diabetes Treatment and Management 14
- Hyperglycemia and glycemic control in critically ill and hospitalized patients 9
- Hormonal Regulation and Hypertension 3
- Genetics 11
- Diabetes and associated disorders 8
- Co-authors
- Claudius Teupe (1 shared paper)Karl Schöffling (18 shared papers)P.-H. Althoff (11 shared papers)F. Enzmann (1 shared paper)Ulrich Hofmann (2 shared papers)Jens Werner (1 shared paper)Tjark Reblin (2 shared papers)Daniela Seidel (2 shared papers)
- Journals
- Hormone and Metabolic Research (3 papers)Diabetologia (2 papers)International Journal of Clinical Practice (2 papers)Journal of Molecular Medicine (2 papers)Diabetes Care (2 papers)
- Partner nations
- GermanyUnited StatesEstonia
In The Last Decade
Ch. Rosak
37 papers receiving 401 citations
Peers
Comparison fields: 5 of 78
- Endocrinology, Diabetes and Metabolism 172
- Cardiology and Cardiovascular Medicine 113
- Biochemistry 22
- Pharmacology 30
- Nutrition and Dietetics 26
Countries citing papers authored by Ch. Rosak
This map shows the geographic impact of Ch. Rosak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ch. Rosak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ch. Rosak more than expected).
Fields of papers citing papers by Ch. Rosak
This network shows the impact of papers produced by Ch. Rosak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ch. Rosak. The network helps show where Ch. Rosak may publish in the future.
Co-authors
The 25 scholars most cited alongside Ch. Rosak, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The HOPE (Heart Outcomes Prevention Evaluation) Study: The design of a large, simple randomized trial of an angiotensin converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events | 1996 | 135 |
| 2 | 2004 | 48 | |
| 3 | 2012 | 39 | |
| 4 | 1982 | 24 | |
| 5 | Spontaneous platelet aggregation and coagulation parameters as risk factors for arterial occlusions in diabetics. Results of the PARD-study. | 1987 | 23 |
| 6 | 1995 | 23 | |
| 7 | 2005 | 18 | |
| 8 | The effect of combination treatment with acarbose and glibenclamide on postprandial glucose and insulin profiles: additive blood glucose lowering effect and decreased hypoglycaemia. | 2002 | 18 |
| 9 | 1982 | 16 | |
| 10 | 2003 | 10 | |
| 11 | Modification of beta-cell response to different postprandial blood glucose concentrations by prandial repaglinide and combined acarbose/repaglinide application. | 2004 | 9 |
| 12 | 2001 | 9 | |
| 13 | 2006 | 7 | |
| 14 | Haemostasiological parameters as risk factor for new arterial occlusions in diabetics. | 1986 | 7 |
| 15 | 1986 | 7 | |
| 16 | 2001 | 6 | |
| 17 | Hormonal and metabolic parameters following insulin-induced hypoglycemia. | 1982 | 6 |
| 18 | 1985 | 5 | |
| 19 | 2009 | 5 | |
| 20 | [Effect of Diclofenac on glucose tolerance of diabetic patients]. | 1977 | 4 |
About Ch. Rosak
Ch. Rosak is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics, Molecular Biology, Cardiology and Cardiovascular Medicine and Surgery, having authored 45 papers that have together received 447 indexed citations. Recurring topics across this work include Diabetes Management and Research (14 papers), Diabetes Treatment and Management (14 papers), Metabolism, Diabetes, and Cancer (12 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (9 papers), Diabetes and associated disorders (8 papers), Diet and metabolism studies (4 papers), Peripheral Artery Disease Management (3 papers) and Hormonal Regulation and Hypertension (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (172 citations), Cardiology and Cardiovascular Medicine (113 citations), Biochemistry (22 citations), Pharmacology (30 citations) and Nutrition and Dietetics (26 citations). Ch. Rosak has collaborated with scholars based in Germany, United States and Estonia. Frequent co-authors include Claudius Teupe, Karl Schöffling, P.-H. Althoff, F. Enzmann, Ulrich Hofmann, Jens Werner, Tjark Reblin, Daniela Seidel, Ute Hofmann and R. Petzoldt. Their work appears in journals such as Hormone and Metabolic Research, Diabetologia, International Journal of Clinical Practice, Journal of Molecular Medicine and Diabetes Care.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.